Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03828929 · ClinicalTrials.gov registry record · Phase 3
Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock
A Phase 3 study, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT03828929: Clinical Trial Phase 3 study, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
NCT03828929 is a Phase 3 study that was terminated before completion, run by New York Presbyterian Brooklyn Methodist Hospital. The registered enrollment target is 3 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03828929, a Phase 3 study, was terminated before completion, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
Preliminary studies show that giving a "cocktail" of intravenous vitamin C, vitamin B1, and steroids to critically ill patients with septic shock may dramatically improve mortality in those patients. These studies suffer from inadequate design due to lack of controls and blinding to prove the causal effect. Our goal is to conduct a prospective blinded randomized control trial to investigate whether this intervention truly effect outcomes.
Primary Outcome
In Hospital Mortality
Interventions
- DRUG Normal saline
- DRUG Vitamin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-10-15 |
| Est. Completion | 2020-02-04 |
| Phase | Phase 3 |
Why NCT03828929 stopped before completion
NCT03828929 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT03828929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03828929 about?
NCT03828929 is a clinical study titled "Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock". Preliminary studies show that giving a "cocktail" of intravenous vitamin C, vitamin B1, and steroids to critically ill patients with septic shock may dramatically improve mortality in those patients. These studies suffer from inadequate design due to lack of controls and blinding to prove the causal...
What is the current status of trial NCT03828929?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2019-10-15. Estimated completion is 2020-02-04.
What interventions are being tested in trial NCT03828929?
The interventions under investigation include: Normal saline (DRUG), Vitamin C (DRUG).
Who is sponsoring clinical trial NCT03828929?
This trial is sponsored by New York Presbyterian Brooklyn Methodist Hospital, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03828929's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI